Literature DB >> 30251169

Electronically ascertained extended pedigrees in breast cancer genetic counseling.

V Stefansdottir1,2, H Skirton3, O Th Johannsson4, H Olafsdottir1, G H Olafsdottir5, L Tryggvadottir5,6, J J Jonsson7,8,9.   

Abstract

A comprehensive pedigree, usually provided by the counselee and verified by medical records, is essential for risk assessment in cancer genetic counseling. Collecting the relevant information is time-consuming and sometimes impossible. We studied the use of electronically ascertained pedigrees (EGP). The study group comprised women (n = 1352) receiving HBOC genetic counseling between December 2006 and December 2016 at Landspitali in Iceland. EGP's were ascertained using information from the population-based Genealogy Database and Icelandic Cancer Registry. The likelihood of being positive for the Icelandic founder BRCA2 pathogenic variant NM_000059.3:c.767_771delCAAAT was calculated using the risk assessment program Boadicea. We used this unique data to estimate the optimal size of pedigrees, e.g., those that best balance the accuracy of risk assessment using Boadicea and cost of ascertainment. Sub-groups of randomly selected 104 positive and 105 negative women for the founder BRCA2 PV were formed and Receiver Operating Characteristics curves compared for efficiency of PV prediction with a Boadicea score. The optimal pedigree size included 3° relatives or up to five generations with an average no. of 53.8 individuals (range 9-220) (AUC 0.801). Adding 4° relatives did not improve the outcome. Pedigrees including 3° relatives are difficult and sometimes impossible to generate with conventional methods. Pedigrees ascertained with data from pre-existing genealogy databases and cancer registries can save effort and contain more information than traditional pedigrees. Genetic services should consider generating EGP's which requires access to an accurate genealogy database and cancer registry. Local data protection laws and regulations have to be addressed.

Entities:  

Keywords:  BRCA2; Breast cancer; Cancer genetic counseling; Electronically generated pedigrees; Genealogy database

Mesh:

Substances:

Year:  2019        PMID: 30251169     DOI: 10.1007/s10689-018-0105-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  43 in total

1.  The life of family trees and the Book of Icelanders.

Authors:  Gísli Pálsson
Journal:  Med Anthropol       Date:  2002 Jul-Dec

2.  Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.

Authors:  Pål Møller; Anne Irene Hagen; Jaran Apold; Lovise Maehle; Neal Clark; Bent Fiane; Kjell Løvslett; Eivind Hovig; Anita Vabø
Journal:  Eur J Cancer       Date:  2007-06-15       Impact factor: 9.162

3.  Family history: still relevant in the genomics era.

Authors:  Megan Doerr; Kathryn Teng
Journal:  Cleve Clin J Med       Date:  2012-05       Impact factor: 2.321

4.  Iceland-genetic counseling services.

Authors:  Vigdis Stefansdottir; Reynir Arngrimsson; Jon J Jonsson
Journal:  J Genet Couns       Date:  2013-08-15       Impact factor: 2.537

5.  Biomedical science: betting the bank.

Authors:  Bijal Trivedi
Journal:  Nature       Date:  2008-04-24       Impact factor: 49.962

6.  Large-scale whole-genome sequencing of the Icelandic population.

Authors:  Daniel F Gudbjartsson; Hannes Helgason; Sigurjon A Gudjonsson; Florian Zink; Asmundur Oddson; Arnaldur Gylfason; Soren Besenbacher; Gisli Magnusson; Bjarni V Halldorsson; Eirikur Hjartarson; Gunnar Th Sigurdsson; Simon N Stacey; Michael L Frigge; Hilma Holm; Jona Saemundsdottir; Hafdis Th Helgadottir; Hrefna Johannsdottir; Gunnlaugur Sigfusson; Gudmundur Thorgeirsson; Jon Th Sverrisson; Solveig Gretarsdottir; G Bragi Walters; Thorunn Rafnar; Bjarni Thjodleifsson; Einar S Bjornsson; Sigurdur Olafsson; Hildur Thorarinsdottir; Thora Steingrimsdottir; Thora S Gudmundsdottir; Asgeir Theodors; Jon G Jonasson; Asgeir Sigurdsson; Gyda Bjornsdottir; Jon J Jonsson; Olafur Thorarensen; Petur Ludvigsson; Hakon Gudbjartsson; Gudmundur I Eyjolfsson; Olof Sigurdardottir; Isleifur Olafsson; David O Arnar; Olafur Th Magnusson; Augustine Kong; Gisli Masson; Unnur Thorsteinsdottir; Agnar Helgason; Patrick Sulem; Kari Stefansson
Journal:  Nat Genet       Date:  2015-03-25       Impact factor: 38.330

7.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

8.  Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.

Authors:  Lara Gudrun Sigurdardottir; Jon Gunnlaugur Jonasson; Sigrun Stefansdottir; Anna Jonsdottir; Gudridur Helga Olafsdottir; Elinborg Jona Olafsdottir; Laufey Tryggvadottir
Journal:  Acta Oncol       Date:  2012-09       Impact factor: 4.089

9.  Comparison of self-reported and database-linked family history of cancer data in a case-control study.

Authors:  R A Kerber; M L Slattery
Journal:  Am J Epidemiol       Date:  1997-08-01       Impact factor: 4.897

10.  To tell or not to tell: barriers and facilitators in family communication about genetic risk.

Authors:  K Forrest; S A Simpson; B J Wilson; E R van Teijlingen; L McKee; N Haites; E Matthews
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.